NM_020751.3:c.320A>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020751.3(COG6):​c.320A>T​(p.Asp107Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000383 in 1,610,024 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D107A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 3 hom. )

Consequence

COG6
NM_020751.3 missense

Scores

4
9
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 8.31

Publications

2 publications found
Variant links:
Genes affected
COG6 (HGNC:18621): (component of oligomeric golgi complex 6) This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi apparatus. The encoded protein is organized with conserved oligomeric Golgi complex components 5, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
COG6 Gene-Disease associations (from GenCC):
  • COG6-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.046038568).
BP6
Variant 13-39660832-A-T is Benign according to our data. Variant chr13-39660832-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 312133.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00181 (275/152342) while in subpopulation AFR AF = 0.00613 (255/41592). AF 95% confidence interval is 0.00551. There are 1 homozygotes in GnomAd4. There are 125 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COG6NM_020751.3 linkc.320A>T p.Asp107Val missense_variant Exon 3 of 19 ENST00000455146.8 NP_065802.1 Q9Y2V7-1A0A024RDW5
COG6NM_001145079.2 linkc.320A>T p.Asp107Val missense_variant Exon 3 of 19 NP_001138551.1 Q9Y2V7-2A0A140VJG7
COG6XM_011535168.2 linkc.320A>T p.Asp107Val missense_variant Exon 3 of 20 XP_011533470.1
COG6NR_026745.1 linkn.485A>T non_coding_transcript_exon_variant Exon 4 of 20

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COG6ENST00000455146.8 linkc.320A>T p.Asp107Val missense_variant Exon 3 of 19 1 NM_020751.3 ENSP00000397441.2 Q9Y2V7-1

Frequencies

GnomAD3 genomes
AF:
0.00180
AC:
274
AN:
152224
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00612
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000542
AC:
136
AN:
250974
AF XY:
0.000339
show subpopulations
Gnomad AFR exome
AF:
0.00708
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000235
AC:
342
AN:
1457682
Hom.:
3
Cov.:
28
AF XY:
0.000215
AC XY:
156
AN XY:
725508
show subpopulations
African (AFR)
AF:
0.00791
AC:
264
AN:
33386
American (AMR)
AF:
0.000626
AC:
28
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39548
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53000
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000225
AC:
25
AN:
1108740
Other (OTH)
AF:
0.000382
AC:
23
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00181
AC:
275
AN:
152342
Hom.:
1
Cov.:
33
AF XY:
0.00168
AC XY:
125
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00613
AC:
255
AN:
41592
American (AMR)
AF:
0.000915
AC:
14
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000727
Hom.:
0
Bravo
AF:
0.00230
ESP6500AA
AF:
0.00794
AC:
35
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000651
AC:
79
Asia WGS
AF:
0.000867
AC:
3
AN:
3474
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

COG6-congenital disorder of glycosylation Uncertain:2
Jan 21, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Uncertain:1
Dec 27, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

COG6-related disorder Benign:1
Dec 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

COG6-congenital disorder of glycosylation;C3809160:Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.67
BayesDel_addAF
Benign
0.0044
T
BayesDel_noAF
Pathogenic
0.24
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.091
.;T
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.046
T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Uncertain
2.1
M;M
PhyloP100
8.3
PrimateAI
Uncertain
0.58
T
PROVEAN
Pathogenic
-6.3
D;D
REVEL
Uncertain
0.62
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0030
D;D
Polyphen
1.0
.;D
Vest4
0.90
MVP
0.56
MPC
0.41
ClinPred
0.063
T
GERP RS
5.7
Varity_R
0.86
gMVP
0.65
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146229425; hg19: chr13-40234969; COSMIC: COSV104414863; API